Moderna

Latest Moderna news and discussion

Sort by

Content type

Moderna· Business · 11 sources · Aug 24, 2026Story

Industrials Stocks Face Mixed Fundamentals

StockStory’s latest picks span industrials, mid-caps, energy, large caps, and profitable stocks, highlighting selective opportunities like resilient yet cautious outlooks (Herc Holdings, Scorpio Tankers) and mixed fundamentals elsewhere (XPO, Burlington Stores; Bristow Group, EQT; Moderna, MSCI; UFPT, Bel Fuse). The overall theme is that several names show growth potential or strength in fundamentals, while others face margin, cash flow, or valuation headwinds warranting caution.

Business· Aug 24, 2026

0CommentShare

Write a comment…

Moderna· Finance · 5 sources · Aug 19, 2026Story

Wall Street rises as yields ease, Moderna lifts healthcare stocks

U.S. stocks rose modestly as easing government yields supported risk appetite, with Moderna’s strong rally boosting the healthcare sector and lifting major indexes. Investors weighed Fed minutes signaling potential rate hikes against Treasury moves to expand liquidity supports, keeping a wary view on longer-term rate trajectories for tech and other high-flyers.

Finance· Aug 19, 2026

+2

0CommentShare

Write a comment…

Moderna· Health · 543 sources · Aug 19, 2026Story

Melanoma Trial Shows Positive Personalized mRNA Vaccine

Merck and Moderna reported positive Phase 3 results for their personalized mRNA cancer vaccine intismeran autogene (V940/mRNA-4157) added to Keytruda in high-risk, surgically treated melanoma, showing longer recurrence-free survival and reduced distant metastasis with no new safety issues. The companies plan regulatory discussions and potential accelerated approval submissions, with data presentations at upcoming medical meetings and continued follow-up for overall survival.

Health· Aug 19, 2026

+540

0CommentShare

Write a comment…